• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Barry I. Gold Examines the Complex History and Ongoing Impact of Opioids in His Latest Book “We’re Overdosed”

By: AB Newswire
September 15, 2025 at 16:54 PM EDT
Retired pharmacologist Barry I. Gold explores opioid history, policy, and addiction solutions in "We're Overdosed."

Eau Claire, Wisconsin - Pharmacologist and author Barry I. Gold offers a measured and science-based perspective on one of the most urgent public health issues in his book We're Overdosed, published in paperback on November 1, 2022. Drawing from decades of professional experience, Gold outlines the complex development of opioid drugs and addresses the broader implications of both legal and illegal drug use.

We're Overdosed follows the journey of opium from ancient use to its modern derivatives, including morphine and synthetic opioids. With particular attention to the pharmaceutical industry's role, Gold explains how these substances moved from medical necessity to widespread overuse. The book tracks the global expansion of opioid production and discusses how this phenomenon has intersected with regulation, commerce, and social impact.

Gold’s career spans both academia and the pharmaceutical industry. After earning a Ph.D. in pharmacology from Boston University and completing a postdoctoral fellowship at Yale, he taught medical pharmacology before managing international drug development projects at major pharmaceutical firms including Wyeth-Ayerst and BASF’s Knoll Pharmaceutical Corp. These experiences inform the book's perspective on drug approval, marketing, and oversight, as well as the potential role of policy in reducing harm.

Rather than focusing solely on the failures of the past, Gold explores how federal legislation and international cooperation could contribute to meaningful control of opioid misuse. The book also touches on promising new approaches for treating addiction and calls attention to the urgent need for better tools in prevention and recovery.

Barry I. Gold has written for publications such as Woman's Day, History Magazine, Parent.com, and Ducts.org. He is also the author of Boomer Dad and The Fourth. Outside of writing, his personal life is centered in northern New Jersey, where he enjoys woodworking and baking bread. He is the father of two adult children and a teenager, and his reflections throughout the book are grounded in both scientific insight and lived experience.

With We're Overdosed, Gold offers a clear and structured look at how history, science, and policy converge in the opioid crisis. The book contributes to the ongoing conversation about how societies respond to addiction and what role informed policy might play in reducing its long-term effects. The book is available for sale on Amazon.

Media Contact
Company Name: The Wave Media Solutions
Contact Person: Support
Email: Send Email
City: Eua Claire
State: Wisconsin
Country: United States
Website: thewavemediasolutions.com

More News

View More
News headline image
Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast ↗
Today 10:21 EST
Via MarketBeat
Tickers CRM GWRE OKTA RBRK SNOW
News headline image
Five Below and Dollar Tree Earnings Signal a Shopper Shift ↗
Today 7:15 EST
Via MarketBeat
Tickers DLTR FIVE
News headline image
Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead? ↗
December 06, 2025
Via MarketBeat
Tickers ULTA
News headline image
Gates Foundation Sells MSFT Stock—Should Investors Be Worried? ↗
December 06, 2025
Via MarketBeat
Tickers MSFT
MarketBeat Week in Review – 12/1 - 12/5 ↗
December 06, 2025
Via MarketBeat
Tickers AMZN COST CRWD GOOGL IBIT MDB

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap